CROMA-PHARMA GmbH

CROMA-PHARMA GmbH logo
🇦🇹Austria
Ownership
Private
Established
1976-01-01
Employees
251
Market Cap
-
Website
http://www.croma.at

Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-08-28
Last Posted Date
2024-12-09
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
74
Registration Number
NCT03650218
Locations
🇦🇹

Yuvell, Vienna, Austria

🇦🇹

Medizinsche Universität Graz-Klinikum für Dermatologie und Venerologie, Graz, Austria

Study of Etafill in Patients With Cataract Surgery Via the Anterior Chamber

Completed
Conditions
First Posted Date
2018-08-23
Last Posted Date
2024-12-09
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
60
Registration Number
NCT03644862
Locations
🇦🇹

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna, Austria

Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber

Completed
Conditions
First Posted Date
2018-08-23
Last Posted Date
2024-12-10
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
40
Registration Number
NCT03644875
Locations
🇦🇹

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna, Austria

Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-08-02
Last Posted Date
2019-02-26
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
60
Registration Number
NCT03611491
Locations
🇦🇹

MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Vienna, Austria

🇦🇹

Yuvell, Vienna, Austria

A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit

First Posted Date
2018-05-22
Last Posted Date
2024-12-10
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
91
Registration Number
NCT03532126
Locations
🇩🇪

Rosenpark Research, Darmstadt, Hessen, Germany

🇩🇪

RZANY & HUND, Privatpraxis, Berlin, Germany

🇦🇹

Medizinisch Ästhetisches Zentrum Wien, Vienna, Austria

and more 1 locations

Princess® VOLUME Lidocaine for the Correction of Nasolabial Folds

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2017-02-13
Last Posted Date
2018-08-10
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
60
Registration Number
NCT03050710
Locations
🇦🇹

Medical University Graz, Graz, Austria

🇦🇹

MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Wien, Austria

🇦🇹

Ordination Dr. Rudolf Bartsch und Dr. Katrin Bartsch, Wien, Austria

Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

First Posted Date
2017-02-13
Last Posted Date
2024-12-09
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
56
Registration Number
NCT03050749
Locations
🇦🇹

MÄZ WIEN Medizinisch Ästhetisches Zentrum Wien, Wien, Austria

🇦🇹

Ordination Dr. Benjamin Gehl, Wien, Austria

🇦🇹

Medical University Graz, Graz, Austria

Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars

First Posted Date
2017-02-13
Last Posted Date
2024-12-09
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
53
Registration Number
NCT03050723
Locations
🇦🇹

Ordination Dr. Benjamin Gehl, Wien, Austria

🇦🇹

Medical University Graz, Graz, Austria

🇦🇹

MÄZ WIEN (Medizinisch Ästhetisches Zentrum Wien), Wien, Austria

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

First Posted Date
2016-02-09
Last Posted Date
2022-05-19
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
200
Registration Number
NCT02677805

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-02-09
Last Posted Date
2022-05-17
Lead Sponsor
Croma-Pharma GmbH
Target Recruit Count
700
Registration Number
NCT02677298
© Copyright 2024. All Rights Reserved by MedPath